You are hereHome ›
Frontiers operates under an advisory structure that ensures input and buy-in from within and from its partners and the community.
The group is comprised of leadership from Frontiers institutions and components who meet monthly to provide input on key adminsitrative issues.
External Advisory Board (EAB)
The EAB meets annually to provide guideance and advice based on their own experience in leadership roles at other Clinical and Translational Science Award (CTSA) sites around the country. Members include
- Gary Rosenthal, MD, Director of the Institute for Clinical and Translational Research at the University of Iowa
- Julian Solway, MD, Director of the University of Chicago Institute for Translational Medicine
- Bradley Evanoff, MD, MPH, Director of the Institute for Clinical and Translational Sciences at Washington University in St. Louis
The Frontiers leadership will seriously consider all suggestions and concerns raised by the External Advisory Board. The input of this group, however, is advisory and not binding. The director, in consultation with the deputy director, must be able to make all final decisions that affect the Frontiers as a whole. If the External Advisory Board makes a recommendation that is not accepted, the Frontiers director will provide that group a rationale and explanation.